UTAH MEDICAL PRODUCTS INC (UTMD)

Every figure this model derived for UTMD, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2026-06-30.

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

FigureValueXBRL tagAs at
capex 400,000 PaymentsToAcquirePropertyPlantAndEquipment 2026-06-30
cash 87,528,000 CashAndCashEquivalentsAtCarryingValue 2026-06-30
current assets 100,639,000 AssetsCurrent 2026-06-30
current liabilities 2,070,000 LiabilitiesCurrent 2026-06-30
equity 122,033,000 StockholdersEquity 2026-06-30
interest expense 0 InterestPaidNet 2026-06-30
ocf 11,847,000 NetCashProvidedByUsedInOperatingActivities 2026-06-30
revenue 36,107,000 RevenueFromContractWithCustomerExcludingAssessedTax 2026-06-30
sbc 397,000 ShareBasedCompensation 2026-06-30

The ratios

The figures themselves rather than their scores — what somebody looking up UTMD on one particular measure came for.

RatioValue
cash operating margin31.86
current ratio48.62
current ratio reported48.62
dilution pct-7.51
ebit cagr-17.12
ebit yoy-18.67
fcf margin31.7
operating margin28.43
owner earnings margin30.6
revenue growth-7.0
revenue growth per share0.55
roic23.5
rule of 4021.43
sbc pct revenue1.1

What to be careful about

What this model itself distrusts about UTMD's figures. Written by the derivation as it ran, not added afterwards.